Mingyar E, Muhling L, Kulik A, et al. A Regulator Based "Semi-Targeted" Approach to Activate Silent Biosynthetic Gene Clusters. International journal of molecular sciences. 2021;22(14): 7567.By culturing microorganisms under standard laboratory conditions, most biosynthetic gene clusters (BGCs) are not expressed, and thus, the products are not produced. To explore this biosynthetic potential, we developed a novel "semi-targeted" approach focusing on activating "silent" BGCs by concurrently introducing a group of regulator genes into streptomycetes of the Tubingen strain collection. We constructed integrative plasmids containing two classes of regulatory genes under the control of the constitutive promoter ermE*p (cluster situated regulators...
Actinobacteria are among the most prolific sources of medically and agriculturally important compoun...
The issues in new antibiotic discovery are pressing, because the frequent re-discovery of antibiotic...
Summary Salinomycin, an FDA‐approved polyketide drug, was recently identified as a promising anti‐tu...
Natural products produced by organisms are molecules that are structurally and functionally diverse...
Streptomyces are well-known producers of a range of different secondary metabolites, including antib...
Abstract Background Regulatory genes play critical roles in natural product biosynthetic pathways. C...
Filamentous fungi are historically known to be a rich reservoir of bioactive compounds that are appl...
Abstract Background Genome sequencing revealed that Streptomyces sp. can dedicate up to ~ 10% of the...
The increasing number of sequenced fungal genomes revealed a vast of natural product biosynthetic ge...
The discovery of new antibiotics is one of the most urgent tasks facing scientists today. The escala...
Understanding the regulation of a heterologously expressed gene cluster in a host organism is crucia...
Actinomycetes are the main sources of antibiotics. The onset and level of production of each antibio...
ABSTRACT Streptomyces species produce an incredible array of high-value specialty chemicals and medi...
The issues in new antibiotic discovery are pressing, because the frequent re-discovery of antibiotic...
Genome mining provides exciting opportunities for the discovery of natural products. However, in con...
Actinobacteria are among the most prolific sources of medically and agriculturally important compoun...
The issues in new antibiotic discovery are pressing, because the frequent re-discovery of antibiotic...
Summary Salinomycin, an FDA‐approved polyketide drug, was recently identified as a promising anti‐tu...
Natural products produced by organisms are molecules that are structurally and functionally diverse...
Streptomyces are well-known producers of a range of different secondary metabolites, including antib...
Abstract Background Regulatory genes play critical roles in natural product biosynthetic pathways. C...
Filamentous fungi are historically known to be a rich reservoir of bioactive compounds that are appl...
Abstract Background Genome sequencing revealed that Streptomyces sp. can dedicate up to ~ 10% of the...
The increasing number of sequenced fungal genomes revealed a vast of natural product biosynthetic ge...
The discovery of new antibiotics is one of the most urgent tasks facing scientists today. The escala...
Understanding the regulation of a heterologously expressed gene cluster in a host organism is crucia...
Actinomycetes are the main sources of antibiotics. The onset and level of production of each antibio...
ABSTRACT Streptomyces species produce an incredible array of high-value specialty chemicals and medi...
The issues in new antibiotic discovery are pressing, because the frequent re-discovery of antibiotic...
Genome mining provides exciting opportunities for the discovery of natural products. However, in con...
Actinobacteria are among the most prolific sources of medically and agriculturally important compoun...
The issues in new antibiotic discovery are pressing, because the frequent re-discovery of antibiotic...
Summary Salinomycin, an FDA‐approved polyketide drug, was recently identified as a promising anti‐tu...